5,7-dihydroxytryptamine has been researched along with Morphine Abuse in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cervo, L; Romandini, S; Samanin, R | 1 |
| Caillé, S; Espejo, EF; Koob, GF; Stinus, L | 1 |
2 other study(ies) available for 5,7-dihydroxytryptamine and Morphine Abuse
| Article | Year |
|---|---|
Evidence that 5-hydroxytryptamine in the forebrain is involved in naloxone-precipitated jumping in morphine-dependent rats.
Topics: 5,7-Dihydroxytryptamine; Animals; Behavior, Animal; Brain; Humans; Injections, Intraventricular; Male; Morphine; Morphine Dependence; Naloxone; Rats; Reaction Time; Serotonin; Substance Withdrawal Syndrome | 1983 |
Dorsal and median raphe serotonergic system lesion does not alter the opiate withdrawal syndrome.
Topics: 5,7-Dihydroxytryptamine; Adrenergic alpha-Agonists; Animals; Behavior, Animal; Biogenic Amines; Clonidine; Male; Morphine; Morphine Dependence; Motor Activity; Naloxone; Narcotic Antagonists; Narcotics; Opioid-Related Disorders; Raphe Nuclei; Rats; Rats, Sprague-Dawley; Serotonin; Serotonin Agents; Substance Withdrawal Syndrome; Weight Loss | 2002 |